CUL-5 activators belong to a class of chemical compounds that play a pivotal role in modulating the activity of the Cullin-5 (CUL-5) protein, a member of the Cullin-RING E3 ubiquitin ligase (CRL) family. These compounds are characterized by their ability to enhance the E3 ligase activity of CUL-5, thereby influencing the ubiquitin-proteasome pathway, a crucial cellular process involved in the regulation of protein turnover and degradation. The activation of CUL-5 by these compounds is primarily achieved through specific mechanisms that target post-translational modifications and protein-protein interactions within the CUL-5 ubiquitin ligase complex.
One well-known group of CUL-5 activators includes compounds that inhibit the Nedd8-activating enzyme (NAE). Nedd8 is a small ubiquitin-like modifier that regulates the function of CRLs, including CUL-5. By blocking Nedd8 conjugation to CUL-5, these activators prevent its inactivation, allowing CUL-5 to ubiquitinate target proteins effectively. Another subset of CUL-5 activators operates indirectly by modifying the substrate specificity of CUL-5, leading to the targeted ubiquitination and subsequent degradation of specific proteins. These compounds act as molecular switches, controlling the fate of key cellular regulators by guiding them toward proteasomal degradation. The discovery and development of CUL-5 activators have provided valuable insights into the intricate regulation of protein homeostasis within cells, shedding light on the fundamental processes governing cell function and response to various environmental cues. These compounds represent important tools in the study of cellular pathways, offering researchers the means to manipulate protein stability and turnover, thereby uncovering new facets of cellular biology and avenues for future research.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
MLN 4924 | 905579-51-3 | sc-484814 | 1 mg | $286.00 | 1 | |
MLN4924 activates CUL-5 by inhibiting the Nedd8-activating enzyme (NAE), preventing CUL-5 inactivation. | ||||||
Thalidomide | 50-35-1 | sc-201445 sc-201445A | 100 mg 500 mg | $111.00 $357.00 | 8 | |
Thalidomide activates CUL-5 indirectly by promoting the degradation of specific proteins through the CUL-5 ubiquitin ligase complex. | ||||||
Auranofin | 34031-32-8 | sc-202476 sc-202476A sc-202476B | 25 mg 100 mg 2 g | $153.00 $214.00 $4000.00 | 39 | |
Auranofin enhances CUL-5 activity, potentially by promoting the degradation of specific substrates targeted by CUL-5. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
MG-132 indirectly affects CUL-5 activity by blocking the degradation of its substrates. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
Chloroquine modulates CUL-5 activity, possibly by interfering with lysosomal degradation pathways. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
Bortezomib indirectly influences CUL-5 activity by altering the cellular protein degradation landscape. | ||||||
Lenalidomide | 191732-72-6 | sc-218656 sc-218656A sc-218656B | 10 mg 100 mg 1 g | $50.00 $374.00 $2071.00 | 18 | |
Lenalidomide enhances CUL-5 activity by promoting the degradation of specific proteins through the CUL-5 ubiquitin ligase complex. | ||||||
(–)-Nutlin-3 | 675576-98-4 | sc-222086 sc-222086A | 1 mg 5 mg | $122.00 $219.00 | 2 | |
(–)-Nutlin-3 activates CUL-5 indirectly by promoting the degradation of the E3 ligase antagonist MDM2. | ||||||
RO-3306 | 872573-93-8 | sc-358700 sc-358700A sc-358700B | 1 mg 5 mg 25 mg | $66.00 $163.00 $326.00 | 37 | |
RO-3306 indirectly influences CUL-5 activity through cell cycle regulation, as CUL-5 is involved in cell cycle control. | ||||||
MLN7243 | 1450833-55-2 | sc-507338 | 5 mg | $340.00 | ||
MLN7243 enhances CUL-5 activity by promoting the neddylation of CUL-5, similar to MLN4924. | ||||||